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Abstract
Background The radial forearm flap (RFF) is known for its
excellent and reliable results regarding defect coverage though
donor site morbidity represents a persisting problem. Integra is
widely used in reconstructive surgery. This study aims to
assess long-term outcomes regarding functionality and
cosmesis after donor site coverage with respect to esthetic
appearance, scar quality, and wrist function as well as ability
to work after donor site coverage with Integra and split-
thickness skin.
Methods The prospective follow-up exam, after a mean time
of 23.8 months, enrolled 13 patients. Identification of patients’
comorbidities and evaluation of the subjective esthetic out-
come, sensibility, cold intolerance, and scar instability was
assessed by a questionnaire. In clinics, designed Pinch test
assessed scar tissue mobility over the flexor tendons. The
Vancouver Scar Scale (VSS) was calculated; wrist function
and grip strength were determined.
Results The satisfaction score for the esthetic appearance of
the donor site was in average 3.42±0.44. Two patients expe-
rienced an unstable scar and cold intolerance. The VSS result-
ed in a value of 4.2 representing a good result. The pinch test
revealed an average scar mobility of 8 mmwithout any tendon
adhesions. Active range of motion of the wrist was equal to
the non-operated site as was grip strength. The pinch test
showed a significant negative correlation with the VSS mak-
ing it a reliable tool to measure scar quality.
Conclusion Long-term results show an esthetic and functional
successful defect coverage of the RFF donor site by the use of
Integra and split-thickness skin.
Level of Evidence: Level IV, therapeutic study.
Keywords Radial forearm flap . Integra . Reconstruction .
Donor site morbidity . Tendon coverage
Introduction
The radial forearm flap (RFF) is one of the most commonly
applied flaps in plastic surgery. Since its introduction in 1981,
it has evolved to be the standard free flap for defect coverage
in head and neck tumor surgery [1, 2]. Next to this, it can be
applied as a free or pedicled flap for several indications
including reconstruction of upper extremity defects or
phalloplasty and can be raised as a pure fasciocutaneous or a
composite flap including bone, muscle, nerve, or tendon [3,
4]. The main features of the RFF are thin and often hairless
skin, pliability as well as a large and reliable pedicle. Howev-
er, despite the excellent results regarding defect coverage,
donor site morbidity represents a persisting problem, which
needs to be further addressed in order to improve overall
outcome. Defect coverage of the donor site typically is
achieved by application of a split-thickness skin graft
(STSG). Often, these grafts do not heal properly resulting in
exposed tendons, prolonged wound healing, and even
reoperations [5]. Skin graft loss in major studies has been
reported to be as high as 28 % [6]. Moreover, STSG use for
defect coverage often may lead to tendon adhesion, reduced
range of motion, and poor cosmesis [7]. Several efforts have
been made to lower donor site morbidity including modifica-
tion of dissection techniques, coverage with full-thickness
skin grafts (FTSG), local flaps to achieve primary closure, or
avoiding the flap in total and choosing free flaps with less
donor site morbidity instead [8, 9].
Soft tissue coverage with Integra dermal regeneration tem-
plate has been successfully used in reconstructive and burn
surgery to increase the thickness of the resulting skin and to
cover underlying structures like bone or tendon [10].
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However, it requires a two-stage procedure before final defect
coverage to allow for adequate vascularization of the template
[11]. Integra provides an immediate donor site coverage inde-
pendent of wound size [12]. As an additional benefit, it creates
a gliding surface between the underlying structures, e.g.,
paratenon or nerves and the STSG. Despite these beneficial
properties, it has been investigated in the past only in two
short-term clinical studies to cover the RFF donor site with
satisfactory immediate results [7, 13]. However, no long-term
outcomes have been reported so far.
Therefore, the aim of this prospective follow-up study was
to investigate the long-term outcome with respect to esthetic
appearance, scar quality, and wrist function as well as ability
to work after donor site coverage following RFF elevation
with Integra and STSG.
Material and methods
Integra dermal regeneration template
Integra dermal regeneration template (Integra Life Sciences,
Plainsboro, NJ, USA) is a template consisting of an outer
silicone layer and an inner dermal replacement layer,
consisting of cross-linked type-1 bovine tendon collagen coat-
ed with glycosamino-glykan. The chondroitin-6-sulfate serves
as a three-dimensional pattern like normal dermal fibers. This
inner layer acts as a tissue scaffold for dermal cellular in-
growth and remodeling without contraction and scarring.
Meanwhile, the outer silicone layer imitates epidermal skin
acting as a protective fluid barrier [7].
RFF harvest and coverage of the donor site
Patients underwent RFF elevation in a subfascial plane pref-
erably from the non-dominant arm. Briefly, the Allen test was
performed preoperatively. The flap was outlined according to
the size of the defect. Dissection then was started from the
ulnar side, including the fascia and deepened toward the radial
artery. Special attention was given to leave the paratenon of the
flexor tendons intact. The donor site thenwas downsized partly
by primary closure of the defect. On the residual defect site, an
Integra sheet of respective size was attached with clips and a
tie-over dressing was applied (Fig. 1a). After 3 weeks and
achieved vascularization of the Integra, a STSG from the thigh
was applied in a second intervention (Fig. 1b). Immobilization
of the forearm and wrist in a palmar splint was performed for
3–4 weeks until complete healing had been achieved.
Study design
The study was designed as a prospective follow-up study. In
addition, data analysis was performed in a retrospective
fashion from the patients’ data sheets and reports. Charts of
adult patients of the Department of Plastic and Hand Surgery
at the University Hospital of Zurich, Switzerland, who
underwent RFF elevation between 2005 and 2011 were
reviewed. Before 2008, donor site defect coverage was
achieved by the application of STSG alone. In total, 40 pa-
tients received defect coverage with STSG alone or Integra
and STSG. Patients who received defect coverage by STSG
did not meet the inclusion criteria. Four patients were de-
ceased by the time of follow-up; for three patients, no valid
address was found in the data base and four other patients
were in a state of poor health and therefore not able to
participate.
Exclusion criteria were preoperative disabilities at the do-
nor site extremity, minors, patients with clotting disorders, and
non-German speakers. After receiving approval of the canton-
al ethics committee, 23 patients who received coverage by
Integra and STSG received an array by mail, plus a letter,
outlining the purpose of the study and informing them that the
participation was voluntary. A total of 13 patients enrolled to
follow-up and provided verbal and written informed consent.
Patient questionnaires
The donor site morbidity was estimated by a patient question-
naire concerning patients’ satisfaction with the esthetic out-
come, sensibility, cold sensitivity, and instability of the scar.
The esthetic result was judged by the patients at the time of the
examination on a scale from one to five based on the follow-
ing categories: 5, very satisfied; 4, somewhat satisfied; 3,
neither satisfied nor dissatisfied; 2, somewhat dissatisfied; 1,
very dissatisfied. Instability of the scar was defined by recur-
ring ulceration after minimal trauma, e.g., wearing a sweater
or a watch on the operated forearm. Additionally, patients
were questioned concerning a distracting cold intolerance of
the scar, problems to resume their original profession after the
operation, and the payment of a disability pension.
A second questionnaire aimed at data acquisition about risk
factors for poor wound healing (medication with ASS, ste-
roids, immunosuppressants, nicotine abuse, and systemic dis-
ease) as well as obtaining information on risk factors for poor
scarring, such as gender, race and age, performance, and
duration of scar massage as well as application of silicone
sheets. Previous operations on the respective arm and pre-
existing limitations of function were recorded.
Clinical examination
A clinical examination between the operated and the non-
operated arm was conducted during the follow-up examina-
tion. Scar quality was determined by the examiner based on
the Vancouver Scar Scale (VSS) divided into the subgroups
pigmentation, vascularity, pliability, height, pain, and itching
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[14]. All scars were photographically documented (Fig. 1c, d).
Scar pliability was measured by the pinch test (Fig. 2). The
pinch test was standardized by lifting a skin fold 1 cm from the
lateral and 1 cm from the medial border and measuring its
height. The sum was divided by two. A value of 5 mm or
greater represented a good tissue laxity including the ability to
separate the skin from underlying structures. Sensibility was
determined by two-point discrimination (2 PD) at four differ-
ent areas of the scar. A 2 PD of 30 mm or less was rated as
positive and the sensibility determined to be intact. Sensibility
was rated to be partially intact of the 2 PD was less than
30 mm in more than 50 % of the tested spots.
Active range of motion (aROM) of the wrist with respect to
extension/flexion and pronation/supination was determined.
The non-operated side was set as a control. Active range of
motion was defined with a goniometer. If the operated side
showed a difference of more than 10° compared to the non-
operated side, this was classified as pathologic. Additionally,
grip strength of the hand and the thumb pinch test were
performed. Assessment was done by the patient squeezing
the examiners hands while applying the maximal possible
force. Pinch or grip strength of the healthy collateral site was
defined as possible maximal power to be achieved. Results
were measured by establishing a scale from 0 to 5 according to
the Medical Research Council scale for muscle strength in
which the patients’ effort is classified as follows: 5, normal
muscle contraction against full resistance; 4, reduced muscle
strength and muscle contraction against resistance; 3, further
reduced muscle strength, joint can be moved only against
gravity with the examiner’s resistance completely removed;
2, muscle move if the resistance of gravity is removed; 1, trace
or flicker of movement or fasciculations observed in the
muscle; 0, no movement observed. The presence of any
contractures of fingers and wrist as well as the presence of
contracting scar bands was evaluated.
Patient characteristics
Patient characteristics are shown in Table 1. Mean follow-up
time was of 23.8 months (range 6–51 months). Nine out of 13
patients successfully underwent defect coverage of the head
and neck after tumor resection. Three patients had undergone
the creation of a phalloplasty, and one patient presented with a
lower extremity soft tissue defect. Scar massage was performed
by seven out of 13 patients. The mean duration was 7.9 months
(range 0–12 months). A silicone sheet was applied only by
three patients in average for 6.7 months (range 1–15 months).
Statistical analyses
After proving the assumption of normality and equal variance
across groups, differences between groups were assessed
Fig. 1 Defect coverage with
Integra: a intraoperative view,
b 3 weeks postoperative with
applied STSG, c 24 months
postoperative, d 51 months
postoperative. Pictures were taken
from different patients
Fig. 2 Pinch test: a skin fold is lifted 1 cm from the lateral and 1 cm from
themedial border. Values are added and the sum is divided by two to yield
the final score
Eur J Plast Surg (2014) 37:159–166 161
using one-way ANOVA followed by the appropriate post hoc
comparison test. Mann–Whitney U tests were applied for
nonparametric distributions. Overall statistical significance
was set at p<0.05. Values are given as mean and range or
mean and SEM. Correlation analysis was performed using the
Pearson test. Statistics and graphics were performed using
the software packages SigmaStat and SigmaPlot (Jandel
Corporation, San Rafael, CA, USA).
Results
Patient satisfaction with esthetic outcome
The mean satisfaction score for the esthetic appearance of the
donor site at the time of follow-up in our patient collective was
3.42±0.44. There was no correlation between the score and
the time after the operation; thus, scar maturity had no influ-
ence on the subjective esthetic judgment of the patients. Both
patients with unstable scars rated esthetic outcome as value 1.
Transsexual patients after creation of a phalloplasty showed a
tendency towards less satisfaction with the esthetic appear-
ance (2.5±0.9 phalloplasty vs. 3.7±0.5 defect coverage; p=
0.2). Correlation analysis showed no significant relationship
between the subjective esthetic estimations of the patients and
the VSS established by the examiner. Also, there was no
correlation with the presence of cold intolerance or the donor
site with respect to dominant or non-dominant hand. Next to
this, there was no difference with regard to medication, nico-
tine abuses, or the use of scar massage and silicon sheets.
Scar quality
After Integra and STSG application, donor sites in 12 out of
13 patients healed without problems over a time period of
4 weeks, and no exposure of tendons or necessary operative
revisions of the donor site was reported. One patient reported
an extended wound therapy over a time period of 9 weeks
including regular presentations to the outpatient clinic. Defect
closure could be finally achieved by conservative treatment.
Scar quality assessed by the VSS is illustrated in Fig. 3a. The
lowest possible score on this scale indicating the best scar
quality, i.e., the quality of healthy skin is 0, the highest score is
22 [14]. In our patient, collective VSS averaged 4.2 (range 0–8)
representing a good scar performance. No hypertrophic scars or
keloids were observed. Three patients reported overall dissat-
isfaction with the scar (scores 1 and 2). Considering the single
criteria, vascularity of the scar tissue showed the least favorable
results (mean 1.8, range 0–3) representing a red to purple tissue
color. Next to this, scar pliability showed an average number of
1.8 (range 0–4) representing a tissue quality between supple/
flexible and yielding to pressure. All scars were flat going in
line with the absence of any hypertrophic scarring and keloid
formation, also not in the relatively young scars. Pain and
itching at the scar site were of no major importance, and
maximal values reached were occasional complaints in two
patients per group.
The scar pinch test was in average 7.7±1.3 mm with a
range from 2 to 15 mm. This symbolizes a good movement of
the tissue including the Integra neo-dermis over the underly-
ing structures in particular tendons and nerves. This goes in
line with the absence of major pain problems or movement
restriction. The pliability of the grafted tissue corresponds
with a low rate of scar contractures. A significant negative
correlation between the pinch value and the VSS could be
detected (r=−0.648; p<0.05) (Fig. 3b). Therefore, the newly
established method to estimate tissue mobility and pliability
appears to be valid also to estimate the scar tissue in general.
No significant correlation between VSS and scar massage
or the use of silicone sheets existed. However, patients with
high VSS scores tended to have performed prolonged silicone
sheet application, i.e., in two patients with a VSS of eight
silicone sheets were utilized and scar massage was performed
for 12 months. Interestingly, these two patients were the ones
presenting with unstable scars at the follow-up.
A feeling of cold intolerance at the operation site was
reported by two patients (Fig. 4a). Two patients suffered from
recurring ulceration at the donor site due to minimal trauma.
Two out of 13 patients had a negative 2 PD test on the donor
site of the operated forearm, 6 out of 13 a positive 2 PD, and
Table 1 Patient characteristics
Group Patients
n=13
Age 52.4±4.7 years
Gender
Male 7
Female 6
Race
North European 10
South European 2
Asian 1
Medication
ASS 1
Steroids 1
Immunosuppressants 0
Systemic disease
aHT 5
pAVK 0
DM 1
Nicotine abuse 5.5±3.2 py
Values are gives as mean ± SEM
ASS acetylsalicylic acid, aHT arterial hypertension, pAVK peripheral
arterial artery disease, DM diabetes mellitus, py pack years
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five patients a partially intact 2 PD. Scar contractures
consisting of single cords were seen in two patients with no
functional limitations.
Functional outcome
Mean aROM of the wrist was determined and showed no
relevant impairment in all patients. aROM for extension/
flexion of the wrist on the operated side was in average
103.8±3.6° (range 75–115°) and showed a difference to the
healthy side of more than 10° in four patients (Fig. 4b). In
these four patients, aROM amounted to 92.5±8.8° when
compared with the other patients (108.9±2.3°; p=not signif-
icant). Overall, aROM even in the least favorable cases was
well above a functionally limitation extent, and patients did
not complain about problems using the respective hand in
daily activities.
aROM pronation/supination was 171.2±2.5° in average
(range 155–180°). Regarding pronation and supination, no
patient showed any limitation of more than 10° compared to
the healthy control side. Grip strength on the operated reached
the maximum value of 5 in all patients and showed no limi-
tations compared to the non-operated site. Thumb pinch
strength was 4.9±0.1 in average and found to be slightly
decreased in only one patient. It should be mentioned that
decrease in pinch strength was accompanied with a decrease
in extension in this case. Two patients who had previous
surgery on the forearm, namely osteosynthesis after radial
fracture and a carpal tunnel release did not experience any
functional limitations. No relationship between wrist function
and esthetic outcome, VAS, or pinch test was detected.
Ability to work
Collected data revealed that 11 of our collective of 13 were
employed at the time of surgery. Four out of 11 patients
reported a delayed re-entry into employment. Two of those
patients worked as car chauffeurs, one as a social worker and
one as a referee. One patient working as a farmer had to
undergo a vocational retraining. One patient was not able to
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work anymore at all and received a pension. Especially in
those cases where the RFF has been harvested for the creation
of a phalloplasty, patients undertook strong efforts to hide the
scar on the forearm.
Discussion
In the past 20 years, the RFF has become a standard free flap
in microsurgery with numerous indications and excellent re-
sults with respect to closure of the primary defect [5]. How-
ever, the price of a considerable functional and esthetic mor-
bidity of the weakened donor side often has to be paid [9].
Skin graft loss in major operative series has been as high as 16
to 28 % and implies exposed flexor tendons, prolonged
healing times, or necessary reoperations to close the donor
site defect [6, 15]. This is particularly of interest since the
patients’ health conditions receiving defect coverage by RFF
usually is quite poor. Plastic surgeons may face an immuno-
suppressed patient, undergoing radiation, and/or chemothera-
py. Therefore, there is a need for a safe and reliable method of
donor site defect coverage.
Numerous attempts to reduce donor site morbidity have
been made in the past decades. An ulnar artery perforator flap
reliably covered defects up to 12×6 cm [16]. Karimi et al.
recommended a closing technique with a purse string suture
and covering the residual defect with a STSG [3].When defect
coverage is performed with STSG, the chance of providing a
gliding surface for a functional tendon without adhesions is
low. In the presented study, 12 out of 13 donor sites healed
within the usual time frame of 4 weeks, and no tendons or
other structures were exposed within the wound. However,
this result also may be achieved with a meticulous dissection
technique leaving the paratenon intact and thus providing a
favorable wound bed even for a STSG alone. To avoid the
donor site morbidity after skin harvest, STSG autologous skin
equivalents can be used on top of Integra with good functional
and esthetic results even though skin color is not matching
[17]. As an alternative, the STSG can be harvested from the
primary flap [18].
Next to this, no patient of the presented study experience
tendon adhesions, nerve irritations, pain, or presented with a
significant loss in aROM of the wrist and hand. In line with
Shores et al. [12], we did not witness any case of acute
complications, i.e., infection of the Integra template or signif-
icant skin graft loss during incorporation. Only one patient
experienced initial partial take of the STSG over the flexor
tendon requiring extended observation and wound therapy for
9 weeks.
Davis et al. compared STSG and FTSG for donor site
coverage [19]. In this study, donor site healing times were
proven to be similar for STSG and FTSG under standardized
conditions including a general satisfaction with donor site
scars in both groups. Even though a FTSG is a reliable option
for defect coverage, defect size is a major limitation. Addi-
tionally, the rate of FTSG take reported in literature between
84 and 88 % is typically lower than published rates of 84–
98 % for STSG [7]. Poor graft taking of FTSG often results in
hypertrophic scars, which is a common esthetic concern in
patients. Also, FTSG donor site morbidity cannot be neglected
[7]. Integra can be easily outlined at the size of the defect and
therefore represents a safe and reliable way of defect coverage
with reproducible results. Thus, by combination of Integra and
a STSG, a full-thickness skin can be re-created. This goes in
line with the results of our study. The VSS yielded a favorable
average value of 4.2 taking into account that also patients who
were operated only 6 months ago were included into the study.
The pinch test showed a satisfactory movement of the scar
over the tendons of 8 mm on both sides of the scar in average
and no adhesions to the underlying tissue were noted. Accord-
ing to the study of Ito et al. who analyzed “what the patient
really bothers” the skin depression by using FTSG was the
most concerning (30%) to patients [8]. STSG are even thinner
than FTSG, so it can be assumed that the overall esthetic
acceptance is even lower.
Defect coverage by Integra and STSG requires a two-stage
procedure, which can be regarded as a disadvantage by the
patient. Jacob et al. compared one stage donor site defect
coverage by Alloderm and STSG vs. STSG alone. Their
results showed superior cosmetic results in the Alloderm and
STSG group than in the control group, as well as in terms of
tendon exposure, functional impairment, and paresthesia with-
out a significant difference [20]. The procedure can be
regarded as an alternative to defect coverage by Integra as a
two-stage procedure. A two-stage procedure requires a
prolonged immobilization. As an alternative single layer,
Integra can be used in a single stage procedure as done by
Demiri et al. with satisfactory functional results, overall take
rate (95–98 %), and pliability as well as overall appearance of
the reconstructed areas (mean Vancouver Scar Scale Score
1.875) [21].
To minimize donor site morbidity further, we have adopted
a careful dissection technique. The remaining paratenon pro-
vides a well-vascularized recipient bed for the Integra tem-
plate. Another possibility to even reduce tendon exposure may
be the preservation of the deep forearm fascia [22]. Results of
previous research are ambiguous: a significant limitation in
range of motion at the harvesting site [23] is shown in some
and disproven in other studies [12]. Kamal et al. showed equal
or better clinical outcomes by adopting the suprafascial dis-
section technique compared to the infrafascial with regard to
tendon adhesion (0 vs. 0) and sensory nerve damage at donor
site (0 vs. 2), with an equal number of flap failure (1/1) [24].
When comparing defect coverage of a suprafascial dissection
technique by FTSG to STSG plus a negative wound pressure,
initial graft taking is as high as 96 % in 5 days and 100 % in a
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month [25]. However, Lutz et al. showed five cases out of 95
with partial skin graft failure when coverage of the
suprafascial defect is performed by FTSG or STSG alone. In
those cases, grip power and pulp-to-pulp pinch power is
significantly decreased [26].
With respect to functionality, our results demonstrate fa-
vorable functional outcomes. We did not observe any limita-
tions in grip strength or wrist movement at the donor site. Four
patients showed a not significantly decreased aROM of more
than 10° difference when compared to the healthy side. In
literature review, similar results are found when using FTSG
on the reconstruction site [7, 8]. If defect coverage was per-
formed with STSG, cases of tendon adhesion are reported as
high as 19–33 %.
While initially the patients’main postoperative concern is the
reconstruction site, the donor site becomes more important to the
patients after approximately 1 year [8]. This may explain why
only seven of the 13 patients performed scar massages and only
three out of 13 used a silicone sheets to improve scar quality.
It is to be noticed that themean satisfaction score after amean
postoperative time to follow-up of 23.77 months is as high as
3.42 out of a maximum of 5. However, still three patients were
dissatisfied with their scar and reported a score of 1 or 2. Studies
comparing STSG to other options of defect coverage report high
dissatisfaction score in up to 39 % of patients [7]. Previous
research also shows a higher dissatisfaction score in female
patients [23]. In comparison to these data, patients treated with
Integra and STSG in our study appear to have a higher satisfac-
tion with the esthetic results overall.
Various publications show that defect coverage by STSG
alone often results in poor wound healing, with a persisting
instability of the scar. Graft failure and tendon exposure rates
are reported as high as 30 to 50 % in several series [27].
According to our literature research, there has been no long-
term follow-up after RFF elevation with regard to instability
of the scar reported. However, our study shows scar instability
in only two patients when defect coverage is performed with
Integra and STSG. This may at least in part be due to the high
proportion of sensible scars in our patient collective. Next to
this, the thicker resulting neo-dermis most likely leads to a
more stable and less vulnerable scar. Even though the benefits
of the Integra scaffold are obvious, the additional costs of
approximately EUR 1,900 per piece of 10×12.5 cm have to
be taken into account. Even though this adds to the total cost
of the operation, a better long-term outcome and a quicker
recovery will reduce costs in long-term.
In four patients of our study group, the RFF served either
for the construction of a phallus in the process of sex change
or reconstruction after a traumatic soft tissue defect. They
presented to surgery as healthy individuals without any men-
tionable comorbidities, with an average age of 37 years. Those
patients had a higher resentment in general about the anes-
thetic appearance on the forearm than tumor patients.
In conclusion, our data show that defect coverage of the
donor site after RFF elevation can be successfully achieved by
Integra and STSG with stable and satisfactory long-term es-
thetic and functional results. Even after suprafascial dissection
of the radial flap, it is advisable to perform donor site defect
coverage with a skin equivalent to avoid depression of the
defect site, especially for patients with high expectations
regarding the esthetic outcome.
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